NAVCO Pharmaceuticals Inc.

NAVCO Pharmaceuticals Inc. — SEDAR+ Filings

All Annual Reports 7 Quarterly Reports 21 MD&A 28 News Releases 17 Material Changes 6 Prospectuses 2 Governance 12 Certifications 61 Other 59

Document	Type	Filing Date	Period	Status
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF	Other	2026-01-29	--	PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF	Other	2026-01-29	--	PDF
Other.pdf	Other	2025-05-13	--	PDF
Notice of meeting - English.pdf	Other	2025-05-13	--	PDF
Statement of executive compensation (form 51-102F6V) - English.pdf	Other	2025-03-31	--	PDF
Notice of the meeting and record date - English.pdf	Other	2025-03-28	--	PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF	Other	2025-01-28	--	PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF	Other	2025-01-28	--	PDF
Other.pdf	Other	2024-05-14	--	PDF
Notice of meeting - English.pdf	Other	2024-05-14	--	PDF
Other securityholders documents - English.pdf	Other	2024-05-14	--	PDF
Statement of executive compensation (form 51-102F6V) - English.pdf	Other	2024-03-28	--	PDF
Notice of the meeting and record date - English.pdf	Other	2024-03-28	--	PDF
Notice (amended).pdf	Other	2023-09-20	--	PDF
Financial statements of RTO acquirer.pdf	Other	2023-09-19	--	PDF
Financial statements of RTO acquirer.pdf	Other	2023-09-19	--	PDF
Notice.pdf	Other	2023-09-08	--	PDF
Other securityholders documents - English.pdf	Other	2023-04-21	--	PDF
Other.pdf	Other	2023-04-18	--	PDF
Other.pdf	Other	2023-04-18	--	PDF
Other.pdf	Other	2022-12-01	--	PDF
Other.pdf	Other	2022-12-01	--	PDF
Other.pdf	Other	2022-12-01	--	PDF
Filing statement - English.pdf	Other	2022-12-01	--	PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf	Other	2022-10-25	--	PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf	Other	2022-10-25	--	PDF
Notice of meeting - English.pdf	Other	2021-11-10	--	PDF
Other.pdf	Other	2021-11-10	--	PDF
Other.pdf	Other	2021-11-10	--	PDF
Notice of the meeting and record date - English.pdf	Other	2021-10-08	--	PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf	Other	2021-10-05	--	PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf	Other	2021-10-05	--	PDF
Other.pdf	Other	2021-05-28	--	PDF
Notice of meeting - English.pdf	Other	2021-04-28	--	PDF
Other.pdf	Other	2021-04-28	--	PDF
Other.pdf	Other	2021-04-28	--	PDF
Notice of the meeting and record date - English.pdf	Other	2021-04-05	--	PDF
Other.pdf	Other	2020-10-29	--	PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf	Other	2020-10-27	--	PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf	Other	2020-10-27	--	PDF
Other.pdf	Other	2020-10-06	--	PDF
Notice of meeting - English.pdf	Other	2020-10-06	--	PDF
Other.pdf	Other	2020-10-06	--	PDF
Notice of the meeting and record date - English.pdf	Other	2020-09-03	--	PDF
Other.pdf	Other	2020-05-01	--	PDF
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf	Other	2019-10-17	--	PDF
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf	Other	2019-10-17	--	PDF
Notice of meeting - English.pdf	Other	2019-09-24	--	PDF
Other.pdf	Other	2019-09-24	--	PDF
Other.pdf	Other	2019-09-24	--	PDF
Notice of the meeting and record date - English.pdf	Other	2019-08-23	--	PDF
Decision Document (Final).pdf	Other	2018-10-02	--	PDF
Escrow agreement.pdf	Other	2018-09-28	--	PDF
Auditors' consent letter.pdf	Other	2018-09-28	--	PDF
Consent letter(s) of issuer's legal counsel.pdf	Other	2018-09-28	--	PDF
Other.pdf	Other	2018-09-28	--	PDF
Underwriting or agency agreement.pdf	Other	2018-09-28	--	PDF
Decision Document (Preliminary).pdf	Other	2018-08-13	--	PDF
Other.pdf	Other	2018-08-13	--	PDF